<p>Braidwell LP 在第二季度收購了 Globus Medical, Inc.（紐約證券交易所代碼：GMED - 免費報告）的一項新頭寸，根據該公司在最近向證券交易委員會的披露。該公司收購了 247,200 股醫療設備公司的股票，價值約為 14,590,000 美元。截至最近的 SEC 備案，Braidwell LP 持有 Globus Medical 的 0.18%。</p>
<p>獲取 <strong>Globus Medical</strong> 的提醒：</p>
<p>其他對沖基金最近也對該公司的頭寸進行了調整。Brevan Howard Capital Management LP 在第二季度購買了 Globus Medical 的新股份，價值約為 547,000 美元。Blue Capital Inc.在第二季度購買了 Globus Medical 的股份，價值為 443,000 美元。Ameriprise Financial Inc.在第二季度將其在 Globus Medical 的股份提高了 24.3%。Ameriprise Financial Inc.現在擁有 205,173 股醫療設備公司的股票，價值為 12,109,000 美元，此前在該期間內又購買了 40,090 股。AQR Capital Management LLC 在第二季度將其在 Globus Medical 的股份提高了 397.6%。AQR Capital Management LLC 現在擁有 112,001 股醫療設備公司的股票，價值為 6,595,000 美元，此前在該期間內又購買了 89,491 股。最後，Quantinno Capital Management LP 在第二季度將其在 Globus Medical 的股份提高了 79.4%。Quantinno Capital Management LP 現在擁有 13,450 股醫療設備公司的股票，價值為 794,000 美元，此前在上個季度又購買了 5,952 股。目前，95.16% 的股票由機構投資者持有。</p>
<h2>內部人士下注</h2>
<p>在其他 Globus Medical 的新聞中，董事 Stephen T. Zarrilli 在 11 月 11 日星期二出售了 25,000 股公司的股票。股票以平均價格 84.29 美元出售，總交易額為 2,107,250.00 美元。此次出售在與 SEC 的法律文件中披露，可以通過此超鏈接訪問。此外，SVP Kelly Huller 在 11 月 25 日星期二出售了 7,500 股公司的股票。股票以平均價格 90.00 美元出售，總價值為 675,000.00 美元。此次出售的披露在 SEC 備案中可用。在過去的九十天裏，內部人士出售了 96,042 股公司股票，價值為 8,003,630 美元。內部人士持有公司股票的 18.51%。</p>
<h2>分析師升級和降級</h2>
<p>多家券商對 GMED 發佈了報告。Stifel Nicolaus 在 10 月 28 日星期二的研究報告中開始覆蓋 Globus Medical。他們對該公司發佈了 “持有” 評級，並設定了 64.00 美元的目標價。Wells Fargo &amp; Company 在 11 月 7 日星期五的研究報告中將 Globus Medical 的目標價從 66.00 美元上調至 79.00 美元，並給予該股票 “增持” 評級。Zacks Research 在星期二的研究報告中將 Globus Medical 的評級從 “強力買入” 下調至 “持有”。Truist Financial 在 11 月 18 日星期二的報告中重新發布了 “買入” 評級，並對 Globus Medical 的股票設定了 105.00 美元的目標價（上調自 93.00 美元）。最後，Barclays 在 11 月 10 日星期一的研究報告中將 Globus Medical 的目標價從 106.00 美元上調至 114.00 美元，並給予該股票 “增持” 評級。九位投資分析師對該股票給予了買入評級，六位對公司的股票給予了持有評級。根據 MarketBeat 的數據，Globus Medical 的共識評級為 “適度買入”，平均目標價為 93.00 美元。</p>
<p><strong>查看我們對 GMED 的最新分析</strong></p>
<h2>Globus Medical 股價下跌 2.4%</h2>
<p>GMED 股票在星期五開盤價為 86.77 美元。該股票的市值為 116.1 億美元，市盈率為 27.99，市盈率增長比率為 1.64，貝塔值為 1.07。Globus Medical, Inc.的 12 個月低點為 51.79 美元，12 個月高點為 94.93 美元。該股票的 50 日移動平均價格為 74.46 美元，200 日移動平均價格為 63.77 美元。</p>
<p>Globus Medical（紐約證券交易所代碼：GMED - 獲取免費報告）最後一次公佈季度財報是在 11 月 6 日星期四。該醫療設備公司報告本季度每股收益為 1.18 美元，超出分析師共識預期的 0.79 美元，超出幅度為 0.39 美元。Globus Medical 的股本回報率為 11.52%，淨利潤率為 15.30%。該公司在本季度的收入為 769.05 百萬美元，而分析師預期為 734.58 百萬美元。在去年同期，該公司每股收益為 0.83 美元。該公司的收入同比增長 22.9%。Globus Medical 已將其 2025 財年的指導目標設定為 3.750-3.85 每股收益。整體而言，研究分析師預測 Globus Medical, Inc.在當前財年將發佈 3.44 每股收益。</p>
<h2>關於 Globus Medical</h2>
<p>（免費報告）</p>
<p>Globus Medical, Inc.是一家醫療設備公司，開發和商業化針對美國及國際上肌肉骨骼疾病患者的醫療解決方案。該公司提供脊柱產品，如傳統融合植入物，包括椎弓根螺釘和杆系統、板系統、椎間隔器和用於治療退行性和先天性疾病、畸形、腫瘤和創傷性損傷的椎體切除裝置；運動保留技術的治療選項，包括動態穩定、全椎間盤置換和椎間分離裝置；治療椎體壓縮骨折的介入解決方案；以及包括同種異體移植物和合成替代品的再生生物產品。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過 Globus Medical</li>
<li>如何捕捉股息增加的好處</li>
<li>Synopsys 因 Ansys 整合推動增長而出現看漲轉變</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>你能給自己最好的節日禮物是什麼？Costco 股票</li>
<li>三隻值得購買和持有的醫療保健股息股票</li>
<li>為什麼 Zscaler 股票在 30% 的拋售後可能準備反彈</li>
</ul>
<p><strong>想知道其他對 GMED 持有何種投資的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Globus Medical, Inc. (NYSE:GMED - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Globus Medical 嗎？</h2>
<p>在考慮投資 Globus Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛市場注意到之前購買……而 Globus Medical 並不在名單上。</p>
<p>雖然 Globus Medical 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Globus醫療

<p>Braidwell LP 在第二季度收購了 247,200 股 Globus Medical，價值 1459 萬美元。其他對沖基金也調整了他們的持倉。內部人士出售了價值 800 萬美元的股票。分析師的評級各不相同，普遍共識為 “適度買入”，平均目標價為 93 美元。Globus Medical 的股票開盤價為 86.77 美元，市值為 116.1 億美元。該公司報告了強勁的季度收益，超出預期，每股收益為 1.18 美元，收入為 7.6905 億美元，同比增長 22.9%</p>

<p>Braidwell LP acquired a new position in Globus Medical, Inc. (NYSE:GMED - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm acquired 247,200 shares of the medical device company's stock, valued at approximately $14,590,000. Braidwell LP owned 0.18% of Globus Medical as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Braidwell LP 在第二季度收購了 Globus Medical, Inc.（紐約證券交易所代碼：GMED - 免費報告）的一項新頭寸，根據該公司在最近向證券交易委員會的披露。該公司收購了 247,200 股醫療設備公司的股票，價值約為 14,590,000 美元。截至最近的 SEC 備案，Braidwell LP 持有 Globus Medical 的 0.18%。</p>
</div><p>Get <strong>Globus Medical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Globus Medical</strong> 的提醒：</p>
</div><p>Other hedge funds also recently made changes to their positions in the company. Brevan Howard Capital Management LP bought a new stake in Globus Medical during the 2nd quarter worth approximately $547,000. Blue Capital Inc. purchased a new stake in shares of Globus Medical in the second quarter worth $443,000. Ameriprise Financial Inc. raised its position in shares of Globus Medical by 24.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 205,173 shares of the medical device company's stock valued at $12,109,000 after purchasing an additional 40,090 shares during the period. AQR Capital Management LLC raised its position in shares of Globus Medical by 397.6% during the 2nd quarter. AQR Capital Management LLC now owns 112,001 shares of the medical device company's stock valued at $6,595,000 after purchasing an additional 89,491 shares during the period. Finally, Quantinno Capital Management LP lifted its stake in shares of Globus Medical by 79.4% during the 2nd quarter. Quantinno Capital Management LP now owns 13,450 shares of the medical device company's stock valued at $794,000 after buying an additional 5,952 shares in the last quarter. 95.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他對沖基金最近也對該公司的頭寸進行了調整。Brevan Howard Capital Management LP 在第二季度購買了 Globus Medical 的新股份，價值約為 547,000 美元。Blue Capital Inc.在第二季度購買了 Globus Medical 的股份，價值為 443,000 美元。Ameriprise Financial Inc.在第二季度將其在 Globus Medical 的股份提高了 24.3%。Ameriprise Financial Inc.現在擁有 205,173 股醫療設備公司的股票，價值為 12,109,000 美元，此前在該期間內又購買了 40,090 股。AQR Capital Management LLC 在第二季度將其在 Globus Medical 的股份提高了 397.6%。AQR Capital Management LLC 現在擁有 112,001 股醫療設備公司的股票，價值為 6,595,000 美元，此前在該期間內又購買了 89,491 股。最後，Quantinno Capital Management LP 在第二季度將其在 Globus Medical 的股份提高了 79.4%。Quantinno Capital Management LP 現在擁有 13,450 股醫療設備公司的股票，價值為 794,000 美元，此前在上個季度又購買了 5,952 股。目前，95.16% 的股票由機構投資者持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other Globus Medical news, Director Stephen T. Zarrilli sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $84.29, for a total transaction of $2,107,250.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Kelly Huller sold 7,500 shares of the company's stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 96,042 shares of company stock worth $8,003,630. Insiders own 18.51% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Globus Medical 的新聞中，董事 Stephen T. Zarrilli 在 11 月 11 日星期二出售了 25,000 股公司的股票。股票以平均價格 84.29 美元出售，總交易額為 2,107,250.00 美元。此次出售在與 SEC 的法律文件中披露，可以通過此超鏈接訪問。此外，SVP Kelly Huller 在 11 月 25 日星期二出售了 7,500 股公司的股票。股票以平均價格 90.00 美元出售，總價值為 675,000.00 美元。此次出售的披露在 SEC 備案中可用。在過去的九十天裏，內部人士出售了 96,042 股公司股票，價值為 8,003,630 美元。內部人士持有公司股票的 18.51%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>A number of brokerages have issued reports on GMED. Stifel Nicolaus started coverage on Globus Medical in a research note on Tuesday, October 28th. They issued a &#34;hold&#34; rating and a $64.00 price target for the company. Wells Fargo &amp; Company upped their price objective on Globus Medical from $66.00 to $79.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, November 7th. Zacks Research downgraded Globus Medical from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday. Truist Financial reissued a &#34;buy&#34; rating and issued a $105.00 price target (up from $93.00) on shares of Globus Medical in a report on Tuesday, November 18th. Finally, Barclays upped their price target on Globus Medical from $106.00 to $114.00 and gave the stock an &#34;overweight&#34; rating in a research note on Monday, November 10th. Nine investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat, Globus Medical has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $93.00.</p>
<div class="lb-trans"><p>多家券商對 GMED 發佈了報告。Stifel Nicolaus 在 10 月 28 日星期二的研究報告中開始覆蓋 Globus Medical。他們對該公司發佈了 “持有” 評級，並設定了 64.00 美元的目標價。Wells Fargo &amp; Company 在 11 月 7 日星期五的研究報告中將 Globus Medical 的目標價從 66.00 美元上調至 79.00 美元，並給予該股票 “增持” 評級。Zacks Research 在星期二的研究報告中將 Globus Medical 的評級從 “強力買入” 下調至 “持有”。Truist Financial 在 11 月 18 日星期二的報告中重新發布了 “買入” 評級，並對 Globus Medical 的股票設定了 105.00 美元的目標價（上調自 93.00 美元）。最後，Barclays 在 11 月 10 日星期一的研究報告中將 Globus Medical 的目標價從 106.00 美元上調至 114.00 美元，並給予該股票 “增持” 評級。九位投資分析師對該股票給予了買入評級，六位對公司的股票給予了持有評級。根據 MarketBeat 的數據，Globus Medical 的共識評級為 “適度買入”，平均目標價為 93.00 美元。</p>
</div><p><strong>View Our Latest Analysis on GMED</strong></p>
<div class="lb-trans"><p><strong>查看我們對 GMED 的最新分析</strong></p>
</div><h2>Globus Medical Trading Down 2.4%</h2>
<div class="lb-trans"><h2>Globus Medical 股價下跌 2.4%</h2>
</div><p>Shares of GMED stock opened at $86.77 on Friday. The stock has a market capitalization of $11.61 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 1.64 and a beta of 1.07. Globus Medical, Inc. has a 12-month low of $51.79 and a 12-month high of $94.93. The stock's 50-day moving average price is $74.46 and its 200-day moving average price is $63.77.</p>
<div class="lb-trans"><p>GMED 股票在星期五開盤價為 86.77 美元。該股票的市值為 116.1 億美元，市盈率為 27.99，市盈率增長比率為 1.64，貝塔值為 1.07。Globus Medical, Inc.的 12 個月低點為 51.79 美元，12 個月高點為 94.93 美元。該股票的 50 日移動平均價格為 74.46 美元，200 日移動平均價格為 63.77 美元。</p>
</div><p>Globus Medical (NYSE:GMED - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The medical device company reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $0.79 by $0.39. Globus Medical had a return on equity of 11.52% and a net margin of 15.30%.The company had revenue of $769.05 million during the quarter, compared to analyst estimates of $734.58 million. During the same period in the prior year, the company earned $0.83 earnings per share. The firm's revenue was up 22.9% on a year-over-year basis. Globus Medical has set its FY 2025 guidance at 3.750-3.85 EPS. As a group, research analysts predict that Globus Medical, Inc. will post 3.44 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Globus Medical（紐約證券交易所代碼：GMED - 獲取免費報告）最後一次公佈季度財報是在 11 月 6 日星期四。該醫療設備公司報告本季度每股收益為 1.18 美元，超出分析師共識預期的 0.79 美元，超出幅度為 0.39 美元。Globus Medical 的股本回報率為 11.52%，淨利潤率為 15.30%。該公司在本季度的收入為 769.05 百萬美元，而分析師預期為 734.58 百萬美元。在去年同期，該公司每股收益為 0.83 美元。該公司的收入同比增長 22.9%。Globus Medical 已將其 2025 財年的指導目標設定為 3.750-3.85 每股收益。整體而言，研究分析師預測 Globus Medical, Inc.在當前財年將發佈 3.44 每股收益。</p>
</div><h2>About Globus Medical</h2>
<div class="lb-trans"><h2>關於 Globus Medical</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.</p>
<div class="lb-trans"><p>Globus Medical, Inc.是一家醫療設備公司，開發和商業化針對美國及國際上肌肉骨骼疾病患者的醫療解決方案。該公司提供脊柱產品，如傳統融合植入物，包括椎弓根螺釘和杆系統、板系統、椎間隔器和用於治療退行性和先天性疾病、畸形、腫瘤和創傷性損傷的椎體切除裝置；運動保留技術的治療選項，包括動態穩定、全椎間盤置換和椎間分離裝置；治療椎體壓縮骨折的介入解決方案；以及包括同種異體移植物和合成替代品的再生生物產品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Globus Medical</li>
<li>How to Capture the Benefits of Dividend Increases</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Globus Medical</li>
<li>如何捕捉股息增加的好處</li>
<li>Synopsys 因 Ansys 整合推動增長而出現看漲轉變</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>你能給自己最好的節日禮物是什麼？Costco 股票</li>
<li>三隻值得購買和持有的醫療保健股息股票</li>
<li>為什麼 Zscaler 股票在 30% 的拋售後可能準備反彈</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding GMED?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globus Medical, Inc. (NYSE:GMED - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對 GMED 持有何種投資的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Globus Medical, Inc. (NYSE:GMED - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=GMED"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Globus Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Globus Medical 嗎？</h2>
</div><p>Before you consider Globus Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資 Globus Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globus Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛市場注意到之前購買……而 Globus Medical 並不在名單上。</p>
</div><p>While Globus Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Globus Medical 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Braidwell LP 購買了 247,200 股 Globus 醫療公司的股票，代碼為$GMED